Waystar Holding Corp
About: Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.
Employees: 280
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
313% more first-time investments, than exits
New positions opened: 66 | Existing positions closed: 16
81% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 32
50% more funds holding in top 10
Funds holding in top 10: 4 [Q3] → 6 (+2) [Q4]
42% more funds holding
Funds holding: 116 [Q3] → 165 (+49) [Q4]
38% more capital invested
Capital invested by funds: $3.36B [Q3] → $4.62B (+$1.26B) [Q4]
35% more call options, than puts
Call options by funds: $24.5M | Put options by funds: $18.2M
0.9% more ownership
Funds ownership: 72.17% [Q3] → 73.07% (+0.9%) [Q4]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Barclays Stephanie Davis 50% 1-year accuracy 7 / 14 met price target | 23%upside $45 | Overweight Maintained | 14 Apr 2025 |
Truist Securities Jailendra Singh 37% 1-year accuracy 13 / 35 met price target | 23%upside $45 | Buy Initiated | 14 Mar 2025 |
Canaccord Genuity Richard Close 32% 1-year accuracy 8 / 25 met price target | 37%upside $50 | Buy Maintained | 24 Feb 2025 |
Goldman Sachs Adam Hotchkiss 38% 1-year accuracy 9 / 24 met price target | 43%upside $52 | Buy Maintained | 19 Feb 2025 |
Jefferies Glen Santangelo 45% 1-year accuracy 5 / 11 met price target | 40%upside $51 | Buy Initiated | 11 Feb 2025 |
Financial journalist opinion









